This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Clinical Laserthermia Systems Future Growth

Clinical Laserthermia Systems is forecast to grow earnings and revenue by 52.3% and 53.8% per annum respectively.

52.3%

Earnings growth rate

n/a

EPS growth rate

Medical Equipment earnings growth	27.0%
Revenue growth rate	53.8%
Future return on equity	n/a
Analyst coverage	Low
Last updated	02 Jul 2024

No updates

No updates

Earnings and Revenue Growth Forecasts

OM:CLS BTU B - Analysts future estimates and past financials data (SEK Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	79	N/A	N/A	N/A	1
12/31/2025	54	-27	-24	-22	1
12/31/2024	35	-43	-51	-49	1
3/31/2024	11	-71	-75	-72	N/A
12/31/2023	8	-80	-72	-66	N/A
9/30/2023	8	-63	-74	-70	N/A
6/30/2023	7	-77	-81	-78	N/A
3/31/2023	6	-78	-85	-82	N/A
12/31/2022	6	-71	-82	-82	N/A
9/30/2022	3	-81	-81	-81	N/A
6/30/2022	2	-63	-66	-66	N/A
3/31/2022	2	-68	-71	-71	N/A
12/31/2021	2	-64	-67	-66	N/A
9/30/2021	1	-60	-63	-63	N/A
6/30/2021	2	-57	-55	-55	N/A
3/31/2021	2	-47	-41	-41	N/A
12/31/2020	1	-58	-56	-55	N/A
9/30/2020	1	-58	-54	-53	N/A
6/30/2020	2	-57	-54	-54	N/A
3/31/2020	6	-54	-52	-52	N/A
12/31/2019	6	-43	-39	-39	N/A
9/30/2019	6	-38	-37	-36	N/A
6/30/2019	5	-37	-35	-34	N/A
3/31/2019	1	-41	-44	-43	N/A
12/31/2018	8	-33	-41	-39	N/A
9/30/2018	10	-28	-33	-31	N/A
6/30/2018	11	-24	-33	-31	N/A
3/31/2018	12	-15	-29	-24	N/A
12/31/2017	8	-21	N/A	-24	N/A
9/30/2017	8	-22	N/A	-29	N/A
6/30/2017	8	-26	N/A	-24	N/A
3/31/2017	6	-27	N/A	-23	N/A
12/31/2016	4	-27	N/A	-20	N/A
9/30/2016	1	-27	N/A	-19	N/A
6/30/2016	0	-23	N/A	-22	N/A
3/31/2016	0	-20	N/A	-17	N/A
12/31/2015	N/A	-17	N/A	-19	N/A
9/30/2015	0	-21	N/A	-21	N/A
6/30/2015	0	-20	N/A	-20	N/A
3/31/2015	0	-20	N/A	-19	N/A
12/31/2014	N/A	-18	N/A	-16	N/A
9/30/2014	0	-16	N/A	-18	N/A
6/30/2014	N/A	-16	N/A	-18	N/A
3/31/2014	N/A	-17	N/A	-17	N/A
12/31/2013	N/A	-18	N/A	-18	N/A
9/30/2013	0	-16	N/A	-13	N/A

Earnings vs Savings Rate: CLS BTU B is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: CLS BTU B is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: CLS BTU B is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: CLS BTU B's revenue (53.8% per year) is forecast to grow faster than the Swedish market (1.7% per year).

High Growth Revenue: CLS BTU B's revenue (53.8% per year) is forecast to grow faster than 20% per year.

Future ROE: Insufficient data to determine if CLS BTU B's Return on Equity is forecast to be high in 3 years time